
Bdfavi 800mg Tablet
Marketer
BDR Pharmaceuticals Internationals Pvt
Salt Composition
Favipiravir (800mg)
Overview Bdfavi 800mg Tablet
Viroxal 800mg tablets offer antiviral action, indicated for managing mild to moderate COVID-19 in adults. This medication inhibits viral replication, thus reducing the body's viral burden. Always adhere to your physician's prescribed dosage and regimen; avoid self-administration. Commonly reported adverse effects include elevated blood uric acid, diarrhea, neutropenia, and increased hepatic enzymes. Consult your doctor if any side effects are troublesome. Prior to commencing treatment, disclose any pre-existing severe kidney or liver impairment to ensure safety. Viroxal 800mg is contraindicated during pregnancy, suspected pregnancy, or breastfeeding due to potential harm to the fetus. Furthermore, report any prior hypersensitivity to this medication, uric acid metabolic disorders, or gout history to your doctor.
Uses of Bdfavi 800mg Tablet
Managing Coronavirus Infection (COVID-19)
Major Benefits of Bdfavi 800mg Tablet:
Administer this medication precisely as your physician directs, adhering to the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Bdfavi 800mg Tablets can be consumed with or without food, although consistent timing is recommended.
Common Side effects of Bdfavi 800mg Tablet:
- Increased uric acid level in blood
- Diarrhea
- Decreased white blood cell count (neutrophils)
- Increased liver enzymes
- Increased triglyceride level in blood
How to use Bdfavi 800mg Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Bdfavi 800mg Tablets can be administered with or without food, although consistent timing is recommended.
How Bdfavi 800mg Tablet works:
Avifavir 800mg tablets offer antiviral action against the SARS-CoV-2 virus, inhibiting its replication. This reduction in viral burden limits infection transmission and accelerates patient recovery.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
The safety of consuming alcohol while taking Bdfavi 800mg Tablet is undetermined. Seek medical advice before combining them.
PregnancyUNSAFE
Using Bdfavi 800mg tablets during pregnancy is strongly discouraged due to substantial risks. Pregnant women should consult their physician; research in both animal and human studies has demonstrated considerable harm to the fetus.
Breast feedingUNSAFE
Administering Bdfavi 800mg tablets while breastfeeding is contraindicated. Evidence indicates potential infant toxicity from this medication.
DrivingCONSULT YOUR DOCTOR
The effect of Bdfavi 800mg Tablet on driving ability is unknown. Refrain from driving if you exhibit any symptoms impairing concentration or reaction time.
KidneyCAUTION
For individuals with severely impaired kidney function, the use of 800mg Bdfavi tablets requires careful monitoring. Dosage modification of Bdfavi 800mg tablets may be necessary. Physician consultation is advised.
LiverCAUTION
Individuals with severe hepatic impairment should exercise caution when using 800mg Bdfavi tablets. Dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Bdfavi 800mg Tablet :
Should you forget a dose of Bdfavi 800mg Tablet, take it immediately if you remember. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing pattern. Avoid taking a double dose.
Facts to Know About Bdfavi 800mg Tablet
| Label | Value |
|---|---|
| Type of Compound | Pyrazine-carboxamide-based compound |
| Potential for Dependence | None. |
| Type of Medication | Agents against infection |
